Medicenna Therapeutics provides a 2026 outlook, highlighting strong clinical data for MDNA11 in advanced cancer and plans for a new bifunctional therapy, MDNA113. Read the latest on these Canadian biotech advancements.
Stablepharma and AFT Pharmaceuticals partner to develop fridge-free injectables for anti-infective and oncology markets. Read about this innovation set to transform global medicine access.
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.